Records containing: Metastatic Malignant Solid Neoplasm
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-10-02Testing the Utility of a Novel Website to Help Cancer Patients Plan for Their Future - Phase 2
-
CLINICAL_TRIALS study record update · 2026-04-27Molecular Analysis for Combination Therapy Choice (ComboMATCH)
-
CLINICAL_TRIALS study record update · 2026-04-24Phase I Trial of ZEN003694 (ZEN-3694) in Combination With Capecitabine in Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-04-24DS3201 With Ipilimumab in Patients With Metastatic Aggressive Variant Prostate (AVPC), Urothelial (UC), and Renal Cell (RCC) Carcinomas
-
CLINICAL_TRIALS study record update · 2026-04-24A Phase 2 Study of AZD1775 in SETD2-Deficient Advanced Solid Tumor Malignancies
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-24Molecular Analysis for Combination Therapy Choice (ComboMATCH)
-
CLINICAL_TRIALS study record update · 2026-04-24A Randomized Phase II Study of AMG 510 (Sotorasib) With or Without Panitumumab in Advanced Solid Tumors: A ComboMATCH Treatment Trial
-
CLINICAL_TRIALS study record update · 2026-04-23A Phase I Trial of Vemurafenib in Combination With Cetuximab and Irinotecan in Patients With BRAF V600 Mutant Advanced Solid Malignancies
-
CLINICAL_TRIALS study record update · 2026-04-23NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
-
CLINICAL_TRIALS study record update · 2026-04-23Radiation Therapy for High-Risk Asymptomatic Bone Metastases: A Pragmatic Multicenter Randomized Phase 3 Clinical Trial (PREEMPT)
-
CLINICAL_TRIALS study record update · 2026-04-23Phase II Trial of Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Selected Solid Tumor Malignancies
-
CLINICAL_TRIALS study record update · 2026-04-21A Pilot Study of Atezolizumab (MPDL3280A) Following Adoptive Cell Transfer in Active Hematologic or Solid Tumor Malignancies
-
CLINICAL_TRIALS study record update · 2026-04-17A Phase 2a Study of Group Retreat Psilocybin Therapy for Cancer-Related Anxiety and Depression
-
CLINICAL_TRIALS study record update · 2026-04-16A Phase II Basket Study of the Oral TRK Inhibitor Larotrectinib (BAY2757556) in Subjects With NTRK Amplification Positive and Pan-TRK Positive Tumors
-
CLINICAL_TRIALS study record update · 2026-04-15Can You Hear Me? Assessment of Verbal Comprehension and Cognitive Processes in Patients in the Last Days of Life
-
CLINICAL_TRIALS study record update · 2026-04-15Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases
-
CLINICAL_TRIALS study record update · 2026-04-15A Phase II Clinical Trial to Investigate ARID1A Mutation and CXCL13 Expression in the Pre-Treatment Tumor Samples as a Combinatorial Predictive Biomarker for Immune Checkpoint Therapy in Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-04-15Prophylactic Cement Augmentation for Patients at High Risk for Developing Vertebral Body Compression Fracture Following Spine Stereotactic Radiosurgery: A Randomized Phase II Clinical Trial
-
CLINICAL_TRIALS study record update · 2026-04-14Phase I Trial of DS-8201a (Trastuzumab Deruxtecan) in Combination With Neratinib in Solid Tumors With HER2 Alterations
-
CLINICAL_TRIALS study record update · 2026-04-14Phase 2 Trial of the Combination of the BET Inhibitor, ZEN003694 (ZEN-3694), and the PARP Inhibitor Talazoparib, in Patients With Molecularly-Selected Solid Tumors (ComBET)
-
CLINICAL_TRIALS study record update · 2026-04-13Phase 1 Study of Trastuzumab Deruxtecan (DS-8201a) in Combination With Azenosertib (ZN-c3) in HER2-Expressing/Amplified Gastric/Gastroesophageal Junction Cancer and Other Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-04-13Phase 1b Study of Pidnarulex and Trastuzumab Deruxtecan in Patients With HER2 Expressing Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-04-13Video Intervention to Address Pre-Test Patient Education for Tumor Genomic Testing
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase I/II Study of M3814 and Avelumab in Combination With Hypofractionated Radiation in Patients With Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies
-
CLINICAL_TRIALS study record update · 2026-04-13DURVA+ : Evaluation of the Safety and Pharmacodynamics of Anti-PD-L1 Antibody Durvalumab in Combination With Chemotherapy in Patients With Advanced Solid Tumors